Cargando…

Protective effects of forced exercise against methylphenidate-induced anxiety, depression and cognition impairment in rat

BACKGROUND: Methylphenidate (MPH), a neural stimulant, can cause damages to brain; the chronic neurochemical and behavioral effects of MPH remain unclear. Exercise lowers stress and anxiety and can act as non-pharmacologic neuroprotective agent. In this study protective effects of exercise in MPH-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motaghinejad, Majid, Motevalian, Manijeh, Larijani, Setare Farokhi, Khajehamedi, Zohreh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544126/ https://www.ncbi.nlm.nih.gov/pubmed/26322282 http://dx.doi.org/10.4103/2277-9175.161528

Ejemplares similares

Reduction of Methylphenidate Induced Anxiety, Depression and Cognition Impairment by Various doses of Venlafaxine in Rat
por: Motaghinejad, Majid, et al.
Publicado: (2015)

Preventive Effect of Maternal Forced Exercise on Offspring Pain Perception and Intensity: The Role of 5-HT(2) and D(2) Receptors
por: Motaghinejad, Ozra, et al.
Publicado: (2017)

Attenuation of morphine withdrawal signs, blood cortisol and glucose level with forced exercise in comparison with clonidine
por: Motaghinejad, Majid, et al.
Publicado: (2014)

The effect of maternal forced exercise on offspring pain perception, motor activity and anxiety disorder: the role of 5-HT2 and D2 receptors and CREB gene expression
por: Motaghinejad, Ozra, et al.
Publicado: (2017)

Hepato-Protection Effect of Curcumin Against Methylphenidate-Induced Hepatotoxicity: Histological and Biochemical Evidences
por: Ahmadinasab, Haleh, et al.
Publicado: (2022)

Neuroprotective Effects of Forced Exercise and Bupropion on Chronic Methamphetamine-induced Cognitive Impairment via Modulation of cAMP Response Element-binding Protein/Brain-derived Neurotrophic Factor Signaling Pathway, Oxidative Stress, and Inflammatory Biomarkers in Rats
por: Taheri, Parastoo, et al.
Publicado: (2018)

Possible Role of Cyclic AMP Response Element Binding/Brain-Derived Neurotrophic Factor Signaling Pathway in Mediating the Pharmacological Effects of Duloxetine against Methamphetamine Use-Induced Cognitive Impairment and Withdrawal-Induced Anxiety and Depression in Rats
por: Ramezany Yasuj, Sanaz, et al.
Publicado: (2019)

Duloxetine by Modulating the Akt/GSK3 Signaling Pathways Has Neuroprotective Effects against Methamphetamine-Induced Neurodegeneration and Cognition Impairment in Rats
por: Rahimi Borumand, Mehrasa, et al.
Publicado: (2019)

Evaluation of Anti-inflammatory and Analgesic Activity of the Extract and Fractions of Astragalus hamosus in Animal Models
por: Shojaii, Asie, et al.
Publicado: (2015)

Kefir protective effects against nicotine cessation-induced anxiety and cognition impairments in rats
por: Noori, Negin, et al.
Publicado: (2014)

Study of the effects of controlled morphine administration for treatment of anxiety, depression and cognition impairment in morphine-addicted rats
por: Motaghinejad, Majid, et al.
Publicado: (2016)

Crocin Acting as a Neuroprotective Agent against Methamphetamine-induced Neurodegeneration via CREB-BDNF Signaling Pathway
por: Mozaffari, Shiva, et al.
Publicado: (2019)

Selegiline acts as neuroprotective agent against methamphetamine-prompted mood and cognitive related behavior and neurotoxicity in rats: Involvement of CREB/BDNF and Akt/GSK3 signal pathways
por: Feizipour, Saba, et al.
Publicado: (2020)

Pharmacological evidence for lithium-induced neuroprotection against methamphetamine-induced neurodegeneration via Akt-1/GSK3 and CREB-BDNF signaling pathways
por: Mehrafza, Shafagh, et al.
Publicado: (2019)

Preventive Effects of Duloxetine Against Methamphetamine Induced Neurodegeneration and Motor Activity Disorder in Rat: Possible Role of CREB/BDNF Signaling Pathway
por: Mohammadi, Niloofar, et al.
Publicado: (2019)

Preventive Effects of Forced Exercise against Alcohol-induced Physical Dependency and Reduction of Pain Perception Threshold
por: Motaghinejad, Majid, et al.
Publicado: (2014)

Methylphenidate modulates interactions of anxiety with cognition
por: Gaillard, C., et al.
Publicado: (2021)

Pharmacological Evidences for Curcumin Neuroprotective Effects against Lead-Induced Neurodegeneration: Possible Role of Akt/GSK3 Signaling Pathway
por: Goudarzi, Negin, et al.
Publicado: (2020)

Preventive Role of Cannabinoids Derivate against Methylphenidate-Induced Oxidative Stress and Inflammation: The Hypothetical Function of Keap1/Nrf2/ARE Signaling and Proposal of a Treatment Strategy for Neurodegeneration
por: Sepehr, Afrah, et al.
Publicado: (2021)

Neural resources shift under Methylphenidate: A computational approach to examine anxiety-cognition interplay
por: Saggar, Manish, et al.
Publicado: (2022)

Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI
por: Leijenaar, Jolien F., et al.
Publicado: (2020)

Rosmarinus officinalis and Methylphenidate Exposure Improves Cognition and Depression and Regulates Anxiety-Like Behavior in AlCl(3)-Induced Mouse Model of Alzheimer’s Disease
por: Malik, Nishat, et al.
Publicado: (2022)

Depression, Anxiety, and Apathy in Mild Cognitive Impairment: Current Perspectives
por: Ma, Lina
Publicado: (2020)

An investigation on the effect of strength and endurance training on depression, anxiety, and C-reactive protein's inflammatory biomarker changes
por: Khorvash, Majid, et al.
Publicado: (2012)

Adding extended-release methylphenidate to psychological intervention for treatment of methamphetamine dependence: A double-blind randomized controlled trial
por: Noroozi, Alireza, et al.
Publicado: (2020)

Methylphenidate for Mild Cognitive Impairment: An Exploratory 3-Day, Randomized, Double-Blind, Placebo-Controlled Trial
por: Press, Yan, et al.
Publicado: (2021)

The effects of methylphenidate on cognitive performance of healthy male rats
por: Rostron, Claire L., et al.
Publicado: (2013)

From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
por: Busardò, Francesco Paolo, et al.
Publicado: (2016)

Methylphenidate as a cognitive enhancer in healthy young people
por: Batistela, Silmara, et al.
Publicado: (2016)

Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2023)

Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment
por: Vassilaki, Maria, et al.
Publicado: (2023)

Hypothetical Protective Effects of Crocin Carotenoid against Coronavirus-Induced Organ Damage: The Possible Role of the NF-κB Signaling Pathway
por: Gholami, Mina, et al.
Publicado: (2021)

Anxiety and depression symptoms among caregivers of care-recipients with subjective cognitive decline and cognitive impairment
por: Liang, Xiaoniu, et al.
Publicado: (2016)

Use of Methylphenidate to Improve Cognition in Autism Spectrum Disorder (ASD)
por: Ashraf, S., et al.
Publicado: (2023)

A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment
por: Pink, Anna, et al.
Publicado: (2021)

Patterns of Cognitive Impairment in Hemodialysis Patients and Related Factors including Depression and Anxiety
por: Golenia, Aleksandra, et al.
Publicado: (2023)

Attenuation of Morphine Physical Dependence and Blood Levels of Cortisol by Central and Systemic Administration of Ramelteon in Rat
por: Motaghinejad, Majid, et al.
Publicado: (2015)

Use of Methylphenidate in Coexisting Major Depression, Loss of Libido and Erectile Dysfunction
por: Nazlı, Şerif Bora, et al.
Publicado: (2021)

Anticonvulsant activity of Dorema ammoniacum gum: evidence for the involvement of benzodiazepines and opioid receptors
por: Motevalian, Manijeh, et al.
Publicado: (2017)

Methylphenidate-associated myopathy
por: Vargas, Ana Beatriz, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n67ahbn7ekghk47gs7crtpbjbp